Published in J Clin Oncol on November 30, 2004
Improved estimates of cancer-specific survival rates from population-based data. J Natl Cancer Inst (2010) 2.59
Predicting Life Expectancy in Men Diagnosed with Prostate Cancer. Eur Urol (2015) 2.29
Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program. Urology (2009) 1.80
Late gastrointestinal toxicity after dose-escalated conformal radiotherapy for early prostate cancer: results from the UK Medical Research Council RT01 trial (ISRCTN47772397). Int J Radiat Oncol Biol Phys (2009) 1.19
Lifetime economic burden of prostate cancer. BMC Health Serv Res (2011) 0.96
Secular trends in prostate cancer mortality, incidence and treatment: England and Wales, 1975-2004. BJU Int (2008) 0.92
Polycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomy. Clin Cancer Res (2008) 0.85
Population-based case-control study of PSA and DRE screening on prostate cancer mortality. Urology (2007) 0.82
Acute promyelocytic leukemia: a population-based study on incidence and survival in the United States, 1975-2008. Cancer (2012) 0.82
A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease. Cancer Med (2014) 0.78
The Utility of Molecular Imaging in Prostate Cancer. Curr Urol Rep (2016) 0.78
Factors driving inequality in prostate cancer survival: a population based study. PLoS One (2014) 0.76
Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer. Ann Fam Med (2016) 0.75
Period analysis of prostate cancer survival. J Clin Oncol (2004) 0.75
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Protection from right- and left-sided colorectal neoplasms after colonoscopy: population-based study. J Natl Cancer Inst (2009) 6.21
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Hybrid analysis for up-to-date long-term survival rates in cancer registries with delayed recording of incident cases. Eur J Cancer (2004) 4.16
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Epidemiology of stomach cancer. Methods Mol Biol (2009) 3.72
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Low risk of colorectal cancer and advanced adenomas more than 10 years after negative colonoscopy. Gastroenterology (2009) 1.75
Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer (2010) 1.69
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol (2007) 1.49
An alternative approach to age adjustment of cancer survival rates. Eur J Cancer (2004) 1.48
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res (2009) 1.33
Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol (2011) 1.28
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk. Cancer Epidemiol (2009) 1.24
Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer. Cancer Epidemiol Biomarkers Prev (2011) 1.23
Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol (2004) 1.21
Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC). PLoS One (2012) 1.13
Quality of life in long-term breast cancer survivors - a 10-year longitudinal population-based study. Acta Oncol (2013) 1.10
Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol (2011) 1.06
Cancer survival in Germany and the United States at the beginning of the 21st century: an up-to-date comparison by period analysis. Int J Cancer (2007) 1.05
Meta-analysis: Serum vitamin D and colorectal adenoma risk. Prev Med (2011) 1.02
A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. Hum Mol Genet (2013) 1.00
Male sex and smoking have a larger impact on the prevalence of colorectal neoplasia than family history of colorectal cancer. Clin Gastroenterol Hepatol (2010) 0.98
9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2012) 0.95
Fear of recurrence in long-term breast cancer survivors-still an issue. Results on prevalence, determinants, and the association with quality of life and depression from the cancer survivorship--a multi-regional population-based study. Psychooncology (2013) 0.95
Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis. Prev Med (2013) 0.92
Recent increase in cancer survival according to age: higher survival in all age groups, but widening age gradient. Cancer Causes Control (2004) 0.92
Gamma-glutamyltransferase, general and cause-specific mortality in 19,000 construction workers followed over 20 years. J Hepatol (2011) 0.91
Smoking habits and occupational disability: a cohort study of 14,483 construction workers. Occup Environ Med (2009) 0.90
Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors. Int J Cancer (2014) 0.90
Stage-specific associations between beta blocker use and prognosis after colorectal cancer. Cancer (2014) 0.88
Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions. Genet Epidemiol (2013) 0.86
Genetic variants within miR-126 and miR-335 are not associated with breast cancer risk. Breast Cancer Res Treat (2010) 0.86
Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. Cancer Epidemiol (2013) 0.85
Epidemiology in aging research. Exp Gerontol (2004) 0.83
Trends in breast cancer survival in Germany from 1976 to 2008--a period analysis by age and stage. Cancer Epidemiol (2011) 0.82
Repeated measures of body mass index and risk of health related outcomes. Eur J Epidemiol (2012) 0.82
Gamma-glutamyltransferase and disability pension: a cohort study of construction workers in Germany. Hepatology (2010) 0.81
Liver enzymes: interaction analysis of smoking with alcohol consumption or BMI, comparing AST and ALT to γ-GT. PLoS One (2011) 0.80
Smoking and γ-glutamyltransferase: opposite interactions with alcohol consumption and body mass index. PLoS One (2010) 0.79
Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol Biomarkers Prev (2013) 0.79
Up-to-date monitoring of childhood cancer long-term survival in Europe: methodology and application to all forms of cancer combined. Ann Oncol (2007) 0.79
Serum uric acid and risk of occupational disability: findings from a cohort study of male construction workers in Germany. Arthritis Care Res (Hoboken) (2010) 0.79
Age-specific administration of chemotherapy and long-term quality of life in stage II and III colorectal cancer patients: a population-based prospective cohort. Oncologist (2011) 0.78
Reduction in selective under-ascertainment bias in population-based estimates of cancer patient survival by age adjustment. Eur J Cancer (2005) 0.77
Cost-effectiveness of colonoscopy in screening for colorectal cancer. Arch Intern Med (2002) 0.77
Absence of evidence is not evidence of absence - does structural quality not matter in colorectal cancer patients' satisfaction and quality of life? Onkologie (2012) 0.75
Evaluation of completeness of case ascertainment in Swiss cancer registration. Eur J Cancer Prev (2017) 0.75
Further enhanced monitoring of cancer patient survival by stage-adjusted period analysis. Cancer Epidemiol Biomarkers Prev (2005) 0.75
Period analysis of cancer patient survival in datasets from which the month of diagnosis has been removed. Eur J Cancer (2005) 0.75